Carroll Financial Associates Inc. boosted its stake in Aetna Inc. (NYSE:AET) by 832.6% during the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 6,808 shares of the company’s stock after buying an additional 6,078 shares during the period. Carroll Financial Associates Inc.’s holdings in Aetna were worth $1,033,000 as of its most recent filing with the SEC.
Other large investors have also recently added to or reduced their stakes in the company. Berkshire Asset Management LLC PA boosted its stake in Aetna by 3.5% in the second quarter. Berkshire Asset Management LLC PA now owns 4,173 shares of the company’s stock valued at $634,000 after buying an additional 140 shares during the period. Wagner Bowman Management Corp bought a new stake in shares of Aetna during the second quarter worth $205,000. Hermes Investment Management Ltd. bought a new stake in shares of Aetna during the second quarter worth $1,131,000. Financial Architects Inc boosted its stake in shares of Aetna by 1.8% in the second quarter. Financial Architects Inc now owns 1,746 shares of the company’s stock worth $265,000 after buying an additional 31 shares during the period. Finally, Doyle Wealth Management bought a new stake in shares of Aetna during the second quarter worth $214,000. 91.69% of the stock is owned by institutional investors and hedge funds.
Shares of Aetna Inc. (AET) traded down 0.87% on Friday, reaching $154.45. 1,781,161 shares of the company’s stock traded hands. The company has a 50 day moving average price of $154.81 and a 200 day moving average price of $140.38. Aetna Inc. has a 52 week low of $104.59 and a 52 week high of $161.69. The firm has a market capitalization of $51.29 billion, a price-to-earnings ratio of 34.28 and a beta of 0.54.
Aetna (NYSE:AET) last released its earnings results on Thursday, August 3rd. The company reported $3.42 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $2.34 by $1.08. The firm had revenue of $15.52 billion for the quarter, compared to analysts’ expectations of $15.34 billion. Aetna had a net margin of 2.52% and a return on equity of 20.52%. Aetna’s quarterly revenue was down 2.7% on a year-over-year basis. During the same quarter last year, the company earned $2.21 EPS. On average, equities research analysts predict that Aetna Inc. will post $9.55 earnings per share for the current fiscal year.
TRADEMARK VIOLATION WARNING: “Carroll Financial Associates Inc. Has $1.03 Million Stake in Aetna Inc. (NYSE:AET)” was published by BNB Daily and is the property of of BNB Daily. If you are accessing this report on another publication, it was illegally copied and reposted in violation of U.S. & international copyright & trademark laws. The original version of this report can be read at https://www.baseball-news-blog.com/2017/08/19/aetna-inc-nyseaet-stake-boosted-by-carroll-financial-associates-inc-updated-updated.html.
AET has been the subject of a number of research reports. Royal Bank Of Canada reissued a “buy” rating and issued a $145.00 price target on shares of Aetna in a research report on Monday, April 24th. Cantor Fitzgerald reissued an “overweight” rating and issued a $150.00 price target (up from $140.00) on shares of Aetna in a research report on Wednesday, May 3rd. Stifel Nicolaus reissued a “buy” rating and issued a $150.00 price target (up from $130.00) on shares of Aetna in a research report on Wednesday, May 3rd. Jefferies Group LLC reissued a “hold” rating and issued a $140.00 price target (up from $133.00) on shares of Aetna in a research report on Wednesday, May 3rd. Finally, Cleveland Research raised shares of Aetna from a “neutral” rating to a “buy” rating in a research report on Thursday, May 11th. Seven equities research analysts have rated the stock with a hold rating and seventeen have given a buy rating to the stock. The stock currently has an average rating of “Buy” and a consensus price target of $157.99.
In other Aetna news, EVP Margaret M. Mccarthy sold 27,028 shares of the firm’s stock in a transaction dated Wednesday, June 7th. The shares were sold at an average price of $149.23, for a total transaction of $4,033,388.44. Following the transaction, the executive vice president now owns 33,563 shares of the company’s stock, valued at approximately $5,008,606.49. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. 0.90% of the stock is currently owned by company insiders.
Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.
Receive News & Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related companies with MarketBeat.com's FREE daily email newsletter.